跳至主要内容
临床试验/NCT02196389
NCT02196389终止4 期

Comparison Between 4 Different Nasal Dilators: Objective vs Subjective Parameters

Universitaire Ziekenhuizen KU Leuven1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2014年1月1日最近更新:
适应症
干预措施

试验速览

阶段
4 期
状态
终止
入组人数
100
试验地点
1
主要终点
Peak Nasal Inflammatory Flow

研究概览

简要总结

Several nasal dilators are currently commercially available, and can be applied endonasally (Airmax°, Nozovent and Nasanita°) or externally (Breath Right°). An objective comparison between these dilators has not been made so far, and would help the clinicians to advise the use of any of these dilators. From clinical experience, endonasal dilators are well supported and improve breathing better than the external dilators

详细描述

Several nasal dilators are currently commercially available, and can be applied endonasally (Airmax°, Nozovent and Nasanita°) or externally (Breath Right°). An objective comparison between these dilators has not been made so far,

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients with nasal obstruction due to external nasal valve problems and with positive Cottle sign.
  • •Age > 18 and < 60 years. Ability to give reliable information and written informed consent.

排除标准

  • •Patients with nasal obstruction due to other endonasal anatomic deformities besides external nasal valve dysfunction.
  • •Patients with rhinosinusitis and/or nasal polyps evaluated by nasal endoscopy. Patients with chronic lower airway disease like severe asthma, chronic obstructive pulmonary disease (COPD), bronchiectasis and/or other conditions that interfere with the generation of a reliable Peak Nasal Inspiratory Flow (PNIF) result.

研究组 & 干预措施

Nasanita

Active Comparator

Nasal Dilator

干预措施: Nasal dilator Nasanita (Device)

Breath Right

Active Comparator

Nasal Dilator

干预措施: Nasal dilator Breath Right (Device)

Airmax

Active Comparator

Nasal Dilator

干预措施: Nasal dilator Airmax (Device)

Nozovent

Active Comparator

Nasal Dilator

干预措施: Nasal dilator Nozovent (Device)

结局指标

主要结局

Peak Nasal Inflammatory Flow

时间窗: 4 weeks

Change in Peak Nasal Inflammatory Flow between the 4 different dilators

次要结局

  • preference(4 weeks)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验